Azitra, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
AZTR$0.60-6.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
| For the Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(8,721,866) | $(6,574,359) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 103,059 | 97,950 |
| Loss on lease modification | 8,564 | — |
| Amortization of right-of-use assets | 236,981 | 234,537 |
| Change in foreign currency rates on remeasurement of Canadian fixed assets | — | (14,199) |
| Stock based compensation | 50,598 | 211,875 |
| Change in fair value of warrant liability | (330) | (4,033,996) |
| Loss on issuance of common stock | — | 2,132,800 |
| Gain on disposal of property and equipment | 2,069 | 4,859 |
| Impairment of intangible assets and deferred patent costs | — | 442,793 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 233 | 98,255 |
| Prepaid expenses | 50,970 | 83,584 |
| Other assets | (298) | 229 |
| Tax credits receivable | 91,297 | 108,460 |
| Income tax payable/receivable | (17,214) | 6,836 |
| Accounts payable and accrued expenses | 93,554 | (165,380) |
| Operating lease liability | (229,131) | (231,783) |
| Net cash used in operating activities | (8,331,514) | (7,597,539) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (14,964) | (8,569) |
| Proceeds from sale of property and equipment | 3,153 | — |
| Deferred patent costs | (87,240) | (255,145) |
| Net cash used in investing activities | (99,051) | (263,714) |
| Cash flows from financing activities | ||
| Payment of deferred offering/issuance costs | — | (37,477) |
| Principal payments on finance leases | (11,900) | (10,816) |
| Proceeds from public offerings, net | 1,746,988 | 13,354,691 |
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
| Proceeds from equity line of credit, net | 3,542,636 | — |
|---|---|---|
| Proceeds from exercise of stock options | — | 19,100 |
| Net cash provided by financing activities | 5,277,724 | 13,325,498 |
| Net change in cash and cash equivalents | (3,152,841) | 5,464,245 |
| Cash and cash equivalents at beginning of period | 4,554,719 | 1,795,989 |
| Cash and cash equivalents at end of period | $1,401,878 | $7,260,234 |
| Supplemental disclosure of non-cash investing and financing information: | ||
| Financed insurance premium exchanged for prepaid insurance | $295,560 | $— |
| Purchases of fixed assets in accounts payable | $9,249 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.